MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.
days to go:
Expired
investment:
£1,048,396
The Best dot dot is a positive review website that lets individuals celebrate the good things in life and in turn, enables others to benefit from those experiences. The company aims to create a leading platform, with a large, engaged user base and ultimately to maximise shareholder value. The company has a full robust technology infrastructure and platform in place, consisting of a mix of unique in house technology and tried and tested industry-standard platforms. Significant work has already been done to create the IP that will be purchased by the company and the funds raised will be used to build on the work already done and to take the business to the next level. By increasing the user base, the revenue will rapidly increase as the company introduces additional revenue streams.
days to go:
Expired
investment:
£19,050
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.
days to go:
Expired
investment:
Withheld
Themis is a regulatory technology company that helps organisations mitigate the risk and impact of all forms of financial crime such as money laundering, bribery, corruption, cybercrime, theft, slavery/human trafficking, and fraud. The platform is designed to provide insights and intelligence on the latest threats, trends, and criminal techniques whilst helping clients complete due diligence on their clients, staff, and supply chains. Themis works alongside the Themis Charitable Trust to ensure the reduction of financial crime. The company also supports the UN Global Compact taking into account the fundamental responsibilities of business in the areas of human rights, labour, environment, and anti-corruption. Themis will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£1,300,000
GymBuddy is an online platform that enables consumers to find, book, and attend a gym location, services, or products offered and operated by fitness studios, gyms, trainers, venues, or other third parties. Users can easily, through filtered searches on the app, view descriptions, and contact information of specialists within the fitness industry such as personal trainers, nutritionists, and physiotherapists. The UK fitness industry alone is currently worth over £5 billion. Based on recent statistics, the average gym membership in the UK costs members £40 a month, which often ties them into lengthy contracts. The GymBuddy app will enter the Health & Fitness club sector as a multi-gym membership feature that gives users access to gyms and various fitness plans, without the need for bricks-and-mortar locations under its brand. The company is seeking an investment of £400,000 to expand its brand identity and bring more users to its ecosystem to generate profits.
days to go:
Expired
investment:
Withheld
Screach provides consumer focused venues with the ability to intelligently engage and interact with their customers via installed digital displays (TVs) and mobile phones. The Screen Reach software dynamically changes the screen content to improve its effectiveness in driving more sales by displaying relevant engaging content and promotions.
days to go:
Expired
investment:
£590,000
AgPlus has created a diagnostic platform for detecting human diseases and delivering laboratory instrument results instantly, whilst keeping in mind the business requirements and unmet requirements. The company works in collaboration with leading diagnostics companies to improve and share products quickly and globally. It aims is to become known as a leader in Point of Care diagnosis.
days to go:
Expired
investment:
£65,004
A car-sharing platform for drivers to receive an extra income by allowing the local community to drive their cars instead of leaving it idle and unused. Hiyacar has a acquired an exclusive insurance product with AXA and already has more than 2,000 cars enrolled, with the majority located in London and surrounding urban areas with the intention of expanding further in the future.
days to go:
Expired
investment:
£1,431,885
Tethered Drones Systems Limited (TDS) builds and develops autonomous tethered drones for use in surveillance and communications scenarios. Its product, Tethered UAV, exhibits a flight duration of 24 hours or more with secure communication via a tether. The platform can carry a range of payloads to meet client needs. The company asserts that the product has multiple uses for broadcasters such as telecasting outdoor sporting events. The UAV's blue light services, including search and rescue, holds prominence in high-risk maintenance inspections for oil and gas platforms and wind farms – both on and offshore. The company will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£73,125
Ablatus Therapeutics is a MedTech company developing a one-of-a-kind tissue ablation platform known as Bimodal Electric Tissue Ablation (BETA). This technology has been designed to overcome the limitations of existing products by offering ablation solutions in oncology (tumours) as well as non-oncology targets. With the proceeds, the company will finish the final elements of engineering of the generator and probe. It will also deliver formal safety test data that is a prerequisite for subsequent clinical trials.
days to go:
Expired
investment:
Withheld
